SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling

[1]  E. Markert,et al.  Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma , 2014, Oncotarget.

[2]  R. Xiang,et al.  SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network. , 2013, Cancer letters.

[3]  A. Heimberger,et al.  The Controversial Role of Microglia in Malignant Gliomas , 2013, Clinical & developmental immunology.

[4]  Jeung-Hoon Lee,et al.  Expression and Functional Role of Sox9 in Human Epidermal Keratinocytes , 2013, PloS one.

[5]  A. Richardson,et al.  SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/β-catenin Activation in Breast Cancer* , 2013, The Journal of Biological Chemistry.

[6]  Jun Yuan,et al.  Oncogenic role of SOX9 expression in human malignant glioma , 2012, Medical Oncology.

[7]  Konrad Basler,et al.  The many faces and functions of β‐catenin , 2012, The EMBO journal.

[8]  H. Galera-Ruiz,et al.  WNT pathway in laryngeal squamous cell carcinoma and nasopharyngeal carcinoma , 2012, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[9]  K. Basler,et al.  Focus Review The many faces and functions of b-catenin , 2012 .

[10]  L. Popplewell,et al.  β‐catenin as a potential key target for tumor suppression , 2011, International journal of cancer.

[11]  K. Sugano,et al.  SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans , 2011, Journal of Gastroenterology.

[12]  D. He,et al.  Knockdown of β-Catenin Through shRNA Cause a Reversal of EMT and Metastatic Phenotypes Induced by HIF-1α , 2011, Cancer investigation.

[13]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[14]  Debasis Mondal,et al.  Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer , 2011, Experimental biology and medicine.

[15]  F. Heppner,et al.  Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas , 2010, Oncogene.

[16]  J. Cuzick,et al.  SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. , 2010, Cancer research.

[17]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[18]  H. Stoop,et al.  FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD) , 2008, The Journal of pathology.

[19]  G. Reifenberger,et al.  Expression of SoxE and SoxD genes in human gliomas , 2007, Neuropathology and applied neurobiology.

[20]  J. Foidart,et al.  β-Catenin and ZO-1: Shuttle Molecules Involved in Tumor Invasion-Associated Epithelial-Mesenchymal Transition Processes , 2007, Cells Tissues Organs.

[21]  G. Kristiansen,et al.  In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR , 2007, BMC Molecular Biology.

[22]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[23]  P. Blache,et al.  Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. , 2005, Cancer research.

[24]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.